← Open Payments lookup

ADELL WINLEY: Open Payments

NPI 1154546232 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,976 in 126 payments from 18 companies in 2025. Trend: 2023 $1,928 · 2024 $1,482 · 2025 $2,976

Food & beverage: $2,976
CompanyPaymentsAmount
Janssen Biotech, Inc.12$709
ABBVIE INC.18$432
PFIZER INC.23$357
Ipsen Biopharmaceuticals, Inc10$307
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$215
Madrigal Pharmaceuticals7$186
Ardelyx, Inc.7$159
GENZYME CORPORATION5$141
QOL Medical, LLC5$113
Gilead Sciences, Inc.3$64

Products named: TREMFYA, IQIRVO, XIFAXAN, REZDIFFRA, VELSIPITY, XELJANZ, RINVOQ, IBSRELA.

Industry payments across MD — which companies pay providers there.